|
 |
| home > pmps > summer 2002 > mes or mess? - the creation of management information and the effective use of production data in pharmaceutical manufacturing |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
As a participant in the IT industry and one that has implemented a wide variety of production information systems in several industries, I have seen all too many buzzwords come and go. The name of the game today is management execution systems (MES). According to the hype, MES delivers totally integrated information systems from the production line to the boardroom - a thrilling thought! This article will look at the different areas that are involved in MES and analyse the different data and information needs from the various participants in the production, delivery and decision processes.
Although Table 1 is not exhaustive - neither when it comes to describing the needs of each and every role, nor all the possible roles involved in the production process - it is sufficient for the purpose of analysing the various aspects of an MES system and the fundamental differences in information needs throughout the information chain.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
New PFA SonicLineŽ ultrasonic flowmeters
Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLineŽ ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLineŽ is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >> |
|
 |
